Operational research to develop an M&E study to guide a triple drug stopping decision for lymphatic filariasis in India
Research question
What is the indicator(s) and accompanying M&E strategy that enables country programs to determine when the risk of ongoing transmission of LF has been reduced so that IDA can be stopped with little risk of resurgence of transmission?
Study sites
Simdega and Yadgir Districts, India
In progress
Sample(s)
Total sample size: 58400 Human